John Hopkins University

A hormone released by muscles during exercise has been found to reduce levels of a protein associated with Parkinson’s disease. The promising animal study indicates future therapies may be developed based on the way this hormone improves brain health.

With the fitness wearable market exploding in popularity a team of researchers wondered whether these devices could be used to detect the earliest signs of dementia. A new study suggests that could be possible.

New research has offered valuable insights into the long-term effects of psilocybin-assisted psychotherapy for depression. The study reports more than half the original cohort were still in remission 12 months after the acute psychedelic treatment.

Johns Hopkins Medicine has been awarded a grant by the National Institutes of Health for research investigating psilocybin-assisted psychotherapy to treat tobacco addiction. The grant is the first federal funding in 50 years for psychedelic therapy.

A first-of-its-kind study has found traces of hundreds of unknown chemicals in electronic cigarette vaping liquid and aerosols. The study details a huge array of unidentified chemicals plus a handful of known and potentially harmful compounds.

A drug originally designed to treat Alzheimer’s has been found to reduce obesity and improve heart function in mice. The drug was previously found to be ineffective treating dementia, but it's suggested it could be useful in stimulating fat metabolism.

A new article asserts the condition known as long COVID shares similarities with chronic fatigue syndrome. The researchers say a better understanding into this overlap can inform therapeutics in the future for many kinds of post-viral illnesses.

A new study is showing a novel blood test can detect the presence of lung cancer with over 90 percent accuracy. The test uses artificial intelligence to identify abnormal patterns in fragments of cancer DNA circulating in a patient’s bloodstream.

Cancer becomes far more dangerous when it spreads through the body, known as metastasis. A newly identified protein stops cells getting into the bloodstream – and tumor cells can ignore it, which may reveal a new drug target for cancer treatment.

Although there are glues that work underwater, they typically require at least 24 hours to set – which can be tricky in chaotic marine environments. A new additive, however, reportedly allows underwater resin adhesives to set in just 60 seconds.

One of the problems with gradual-release medications lies in the fact that the pills often pass through the body before all of the medication has been released. An experimental new technology addresses that problem, by copying an intestinal parasite.

A tiny brain lesion can shift a person's reality in bizarre and tragic ways, and their ability to describe their condition can lead us toward a fuller understanding of how our complex mental processes work. Here's another oddity to put on the pile.